# General Electric Co: Form 10-Q for the period ended Sep 30, 2025

- Company: [General Electric Co](/companies/ge.md) (CIK 40545)
- Form: 10-Q
- Filed: 2025-10-21
- Accepted by EDGAR: Oct 21, 2025, 06:27 ET
- Period: 2025-09-30
- Accession: 0000040545-25-000132
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/40545/000004054525000132/ge-20250930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/40545/000004054525000132/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-07-01 to 2025-09-30 | $12.18bn | us-gaap:Revenues |
| Revenue | 9 months, 2025-01-01 to 2025-09-30 | $33.14bn | us-gaap:Revenues |
| Research and development | 3 months, 2025-07-01 to 2025-09-30 | $415.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2025-01-01 to 2025-09-30 | $1.13bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2025-07-01 to 2025-09-30 | $1.20bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2025-01-01 to 2025-09-30 | $3.09bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Income tax | 3 months, 2025-07-01 to 2025-09-30 | $344.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2025-01-01 to 2025-09-30 | $1.01bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-07-01 to 2025-09-30 | $2.16bn | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2025-01-01 to 2025-09-30 | $6.16bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-07-01 to 2025-09-30 | $2.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2025-01-01 to 2025-09-30 | $5.75 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-07-01 to 2025-09-30 | $2.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2025-01-01 to 2025-09-30 | $5.79 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-07-01 to 2025-09-30 | 1,065,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2025-01-01 to 2025-09-30 | 1,071,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2025-01-01 to 2025-09-30 | $6.26bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2025-01-01 to 2025-09-30 | $842.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 9 months, 2025-01-01 to 2025-09-30 | $5.55bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | at 2025-09-30 | $40.07bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-09-30 | $128.24bn | us-gaap:Assets |
| Current liabilities | at 2025-09-30 | $37.20bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-09-30 | $109.22bn | us-gaap:Liabilities |
| Current portion of debt | at 2025-09-30 | $2.07bn | us-gaap:DebtCurrent |
| Short-term borrowings | at 2025-09-30 | $17.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2025-09-30 | $18.81bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2025-09-30 | 1,054,813,911 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/40545/000004054525000132/ge-20250930.htm

Filed Oct 21, 2025.
Source: SEC EDGAR, the filing index for accession 0000040545-25-000132. Last ingested by Listed: Nov 13, 2026, 16:12 ET. No prices; not investment advice.
